Give Online: Help shape patient care for generations to come.
Cleveland Clinic Logo



Request an Appointment



Contact us with Questions

Expand Content

Karen James MD

The Tomsich Family Department of Cardiovascular Medicine
Sydell and Arnold Miller Family Heart & Vascular Institute

  1. James KB, Brodsky MS, Schluchter MD, Whitlow PL, Lucas FV, Hollman JL:  The Relationship Between Intimal Tears During Coronary Angioplasty and Fibrinopeptide A.  J Interven Cardiol 1989; 2:3.
  2. James KB, Obarski TO, Underwood DA:  Electrocardiographic Criteria for Anterior Myocardial Infarction Based on Contrast Ventriculography.   Cleve Clin J Med 1990; 57(7):618-21.
  3. James KB, Centorbi K, Novoa R: The Quadricuspid Aortic Valve. Texas Heart Inst J 1991; 18:141-3.
  4. James KB, Brodsky MS, Lucas FV, Hollman JL, Schluchter MD, Whitlow PL:  The Association of Fibrinopeptide A with Cardiac Events Following Coronary Angioplasty. J Interven Cardiol 1990; 3:3.
  5. James KB:  Myocarditis as a Cause of Impaired Myocardial Function After Aortocoronary Bypass.  Texas Heart Inst J 1989; 16:117-9.
  6. James KB:  Dynamic Cardiomyoplasty:  A Novel Option for Treatment of Refractory Heart Failure.  Cardio-June, 1992;68-73.
  7. James KB, Marwick T, Cosgrove DM:  Underestimation of Mitral Regurgitation Under General Anesthesia.  J Thorac Cardiovasc Surg 1992;104(2):534.
  8. Ashchi M, Wiedemann HP, James KB:  Cardiac Complication From Use of Cocaine and Phenylephrine in Nasal Septoplasty.  Archives of Otolaryngology-Head and Neck Surg 1995; 121:681-684.
  9. James KB, McCarthy PM:  Treatment of Congestive Heart Failure:  Focus on Left Ventricular Assist Devices.  ACC Current Journal Review, July/August 1995; 4(4):51-52.
  10. James KB, Lee K, Thomas J, Hobbs RE, Rincon G, Bott-Silverman C, Ratliff N, Marchant K, Klein AL:  Left Ventricular Diastolic Dysfunction in Lymphocytic Myocarditis As Assessed by Doppler Echocardiography.  Am J Cardiol 1994; 73:282-5.
  11. McCarthy PM, Savage RM, Fraser CD, Vargo R, James KB, Goormastic M, Hobbs RE:  Hemodynamic and Physiologic Changes During Implantable LVAD Support.  J Thorac and Cardiovasc Surg, 1995;109:409-18.
  12. McCarthy PM, James KB, Savage RM, Vargo R, Kendall K, Harasaki H, Pashkow FJ, and The Implantable LVAD Study Group:  Implantable Left Ventricular Assist Device; Approaching an Alternative for End-Stage Heart Failure.  Circulation, 1994; 90 (Part 2):II-83-II-86.
  13. Lee KS, Marwick T, Thomas JD, Cook SA, Fix JS, James KB, Go RT, MacIntyre WJ:  Prognosis of Patients With and Without Viable Myocardium After Myocardial Infarction:  Relative Efficacy of Medical Therapy Versus Revascularization.  Circulation, 1994; 90:2687-2694.
  14. McCarthy PM, Nakatani S, Vargo R, Kottke-Marchant K, Harasaki H, James KB, Savage RM, Thomas JD:  Structural and Left Ventricular Histologic Changes After Implantable LVAD Insertion.  Ann Thorac Surg 1995;59:609-13.
  15. James KB, McCarthy PM, Thomas JD, Vargo R, Hobbs RE, Sapp S, Bravo E:  The Effect of the Implantable Left Ventricular Assist Device on Neuroendocrine Activation in Heart Failure.  Circulation, 1995;92[Suppl II]:II 191- II 195.
  16. Hobbs RE, Miller LW, Grossbard EB, James KB, Rincon G, Bott-Silverman C: Hemodynamic Effects of a Single Intravenous Injection of Human Brain Natriuretic Peptide in Patients with Heart Failure Secondary to Ischemic or Dilated Cardiomyopathy.  Am J Cardiol. 1996;78:896-901.
  17. James KB, McCarthy PM, Jaalouk S, Bravo EL, Betkowski A, Thomas JD, Nakatani S, Fouad-Tarazi FM:  Plasma Volume and Its Regulatory Factors in Congestive Heart Failure Following Implantation of Longterm Left Ventricular Assist Devices.  Circulation. 1996; 93(8):1515-1519.
  18. Nakatani S, McCarthy PM, Kottke-Marchant K, Harasaki H, James KB, Savage RM, Thomas JD: Echocardiographic and Histologic Changes in the Left Ventricle: Impact of Chronic Unloading by an Implantable Ventricular Assist Device.  J Am Coll Cardiol.  1996;27:894-901.
  19. Wang C, Steinhubl SR, Castellani WJ, Van Lente F, James KB, Young JB: Inability of Serum Myocyte Death Markers to Predict Acute Cardiac Allograft Rejection.   Transplantation.  1996;62(12):1938 - 1941.
  20. James KB: Neurohormones and Regulators of Fluid Balance in Longterm LVAD Patients.  Congestive Heart Failure.  1997;3(1):16-18.
  21. Sun JP, James KB, Solanhi N, Shah MS, Lee K, Stewart WJ: Right Ventricular Enlargement Predicts Mortality and Progression of Ventricular Function in Dilated Cardiomyopathy.  Am J Cardiol 1997;80:1583-87.
  22. 22. Gupta A, Moustapha A, Jacobsen DW, Goormastic M, Tuzcu EM, Hobbs R, Young J, James K, McCarthy P, Van Lente F, Green R, Robinson K: High Homocysteine, Low Folate and Low Vitamin B6 Concentrations: Prevalent Risk Factors for Vascular Disease in Heart Transplant Recipients.  Transplantation.  1998; 65 (4):544-550.
  23. James KB, Rodkey S, McCarthy PM, Thomas JD, Blackburn G, Sapp S, Vargo R, Lauer MS, Young JB: Exercise Performance and Chronotropic Response in Heart Failure Patients with Implantable Left Ventricular Assist Devices.  Am J Cardiol 1998; 81:1230-1232.
  24. James KB, Maurer J, Wolski K, Lutton S, Haas G, Schilz R, Rubin D, Young JB: Exercise Hemodynamic Findings in Patients with Exertional Dyspnea.  Texas Heart J 2000;27:100-105.
  25. James KB, Haas G, Lutton SR, Prior D, Wolski K, Buda T, McCarthy PM: Cardiac Exercise Hemodynamics Late After Partial Left Ventriculectomy.  Circulation 2000; 102:III-200-III 203.
  26. James KB, Bott-Silverman C, Houghtaling P, Ratliff N, Magyar W, Nissen S:  Contribution of Vascular Rejection to Progression of Transplant Coronary Disease as Assessed by Serial Intravascular Ultrasound.  Am J Cardiol 2001, 88:38-41.
  27. Mughal MM, Mandell B, James K, Stelmach K, Minai O:  Implementing a Shared-Care Approach  to Improve the Management of Patients with Pulmonary Arterial Hypertension.  Cleveland Clinic J Med 2003;70(suppl 1): S 28-33.
  28. James KB, Stelmach K, Armstrong R, Young JB, Fouad-Tarazi F.  Plasma Volume and Outcome in Pulmonary Hypertension.  Tex Heart Inst J 2003; 30:555-7.
  29. James KB, Troughton RW, Feldschuh J, Soltis, D, Thomas D, Fouad-Tarazi F.  Blood Volume and Brain Natriuretic Peptide in Congestive Heart Failure:  a pilot study.  Am Heart J 2005; 150 (5):984.el-984.e6.
  30. Heerey A, Lauer M, AlSolaiman F, Czerr J, James K.  Cost Effectiveness of Bi-Ventricular Pacemakers in Heart Failure Patients.  Am J of Cardiovasc Drugs  2006; 6(2):129-137.
  31. James KB, Militello M, Gus B, Wilkoff BL.  A Series of Heart Failure Patients Undergoing Resynchronization While on Inotropic Therapy Around the Timing of Pacemaker Insertion.  Texas Inst J 2006; 33:19-22.
  32. Ozduran V, Yamani MY, Chaung HH, Sipahi I, Cook DJ, Sendrey D, Tong L, Hobbs R, Rincon G, Bott-Silverman C, James K, Taylor DO, Young JB, Navia J, Banbury M, Smedira N, Starling RC.  Survival Beyond 10 Years Following Heart Transplantation:  The Cleveland Clinic Foundation Experience:  Transplantation Proc. 2005; 37:4509-4512.
Textbook Chapters:
  1. Heart Disease Arising During or Secondary to Pregnancy.  Karen B. James, M.D., Bernadine P. Healy, M.D.  In:  Cardiovascular Clinics - Heart Disease in Women.  Vol 19:3, F.A. Davis Co., Philadelphia.  November 1988, pp 81-96.
  2. Heart Disease Arising During Pregnancy.  Karen B. James, M.D., In:  Cardiovascular Health and Disease in Women.  W.B. Saunders Co., Orlando, Florida.  1993, pp 337-59.
  3. Inflammatory Cardiomyopathy: The Controversy of Diagnosis and Management.  Karen B. James, M.D., Norman Ratliff, M.D., Randall Starling, M.D., James B. Young, M.D.  In: Rheumatic Disease Clinics of North America.  W.B. Saunders Co., Philadelphia, PA, 1997:333-343.
  4. Women’s Health Initiative: Focus on Risk Factors and Diagnostic Approach to Suspected Coronary Disease.  Karen B. James, M.D., In: The New Cardiology Textbook of Cardiovascular Management for Clinical Practice.  Arnold, New York, NY, 2001:47-60.
  5. Heart Disease Arising From Pregnancy.  Karen B. James, M.D., In: Cardiovascular Health and Disease in Women, Second Edition, W.B. Saunders Co., Orlando, Florida, 2000: Chapter 28:502-509.
Reviewed: 10/09

Talk to a Nurse: Mon. - Fri., 8:30 a.m. - 4 p.m. (ET)

Call a Heart & Vascular Nurse locally 216.445.9288 or toll-free 866.289.6911.

Schedule an Appointment

Toll-free 800.659.7822